These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23696709)

  • 21. A Mobile-Based Intervention for Glycemic Control in Patients With Type 2 Diabetes: Retrospective, Propensity Score-Matched Cohort Study.
    Li J; Sun L; Wang Y; Guo L; Li D; Liu C; Sun N; Xu Z; Li S; Jiang Y; Wang Y; Zhang S; Chen L
    JMIR Mhealth Uhealth; 2020 Mar; 8(3):e15390. PubMed ID: 32159518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early treatment revisions by addition or switch for type 2 diabetes: impact on glycemic control, diabetic complications, and healthcare costs.
    Schwab P; Saundankar V; Bouchard J; Wintfeld N; Suehs B; Moretz C; Allen E; DeLuzio A
    BMJ Open Diabetes Res Care; 2016; 4(1):e000099. PubMed ID: 26925237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: a population-based study using administrative data.
    Oh SH; Ku H; Park KS
    BMC Public Health; 2021 Mar; 21(1):548. PubMed ID: 33743612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Healthcare resource utilization and cost among patients with type 1 diabetes in the United States.
    Simeone JC; Shah S; Ganz ML; Sullivan S; Koralova A; LeGrand J; Bushman J
    J Manag Care Spec Pharm; 2020 Nov; 26(11):1399-1410. PubMed ID: 33119443
    [No Abstract]   [Full Text] [Related]  

  • 26. Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims.
    Robinson RL; Long SR; Chang S; Able S; Baser O; Obenchain RL; Swindle RW
    J Manag Care Pharm; 2006; 12(1):43-54. PubMed ID: 16420107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Status of Metabolic Control in Patients With Type 2 Diabetes Attending Dasman Diabetes Institute, Kuwait.
    Qaddoumi M; Al-Khamis Y; Channanath A; Tuomilehto J; Badawi D
    Front Endocrinol (Lausanne); 2019; 10():412. PubMed ID: 31297092
    [No Abstract]   [Full Text] [Related]  

  • 28. Characteristics of High-Cost Patients Diagnosed with Opioid Abuse.
    Shei A; Rice JB; Kirson NY; Bodnar K; Enloe CJ; Birnbaum HG; Holly P; Ben-Joseph R
    J Manag Care Spec Pharm; 2015 Oct; 21(10):902-12. PubMed ID: 26402390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease.
    Gandra SR; Lawrence LW; Parasuraman BM; Darin RM; Sherman JJ; Wall JL
    J Manag Care Pharm; 2006 Sep; 12(7):546-54. PubMed ID: 16981800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of a diabetes collaborative care management program on clinical and economic outcomes in patients with type 2 diabetes.
    McAdam-Marx C; Dahal A; Jennings B; Singhal M; Gunning K
    J Manag Care Spec Pharm; 2015 Jun; 21(6):452-68. PubMed ID: 26011547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age, gender, insulin and blood glucose control status alter the risk of ischemic heart disease and stroke among elderly diabetic patients.
    Hayashi T; Kawashima S; Nomura H; Itoh H; Watanabe H; Ohrui T; Yokote K; Sone H; Hattori Y; Yoshizumi M; Ina K; Kubota K;
    Cardiovasc Diabetol; 2011 Oct; 10():86. PubMed ID: 21978180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective database analysis of the impact of prior authorization for type 2 diabetes medications on health care costs in a Medicare Advantage Prescription Drug Plan population.
    Bergeson JG; Worley K; Louder A; Ward M; Graham J
    J Manag Care Pharm; 2013 Jun; 19(5):374-84. PubMed ID: 23697475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis.
    Kostev K; Dippel FW; Rathmann W
    Diabetes Metab Syndr Obes; 2015; 8():45-8. PubMed ID: 25609990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.
    Winkley K; Upsher R; Stahl D; Pollard D; Kasera A; Brennan A; Heller S; Ismail K
    Health Technol Assess; 2020 Jun; 24(28):1-232. PubMed ID: 32568666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resource use and costs in patients with poorly controlled type 2 diabetes mellitus and obesity in routine clinical practice in Spain.
    Díaz-Cerezo S; Romera I; Sicras-Mainar A; López-Simarro F; Dilla T; Artime E; Reviriego J
    Curr Med Res Opin; 2020 Sep; 36(9):1449-1456. PubMed ID: 32643441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Geographic Variation in Antidiabetic Agent Adherence and Glycemic Control Among Patients with Type 2 Diabetes.
    Tan E; Yang W; Pang B; Dai M; Loh FE; Hogan P
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1195-202. PubMed ID: 26679968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health economic evaluation of type 2 diabetes mellitus: a clinical practice focused review.
    Liebl A; Khunti K; Orozco-Beltran D; Yale JF
    Clin Med Insights Endocrinol Diabetes; 2015; 8():13-9. PubMed ID: 25861233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and Impact of Psychological Disorders on Pharmacotherapy of Diabetic Patients in Low Resource Settings: A Prospective Assessment in Primary Healthcare Settings.
    Shahbaz K; Alamgeer ; Paudyal V; Zubair M; Safdar MZ; Tahir M; Akram L; Ali S
    Patient Prefer Adherence; 2024; 18():1939-1948. PubMed ID: 39315346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Socioeconomic Factors Associated With Glycemic Measurement and Poor HbA1c Control in People With Type 2 Diabetes: The Global DISCOVER Study.
    Gomes MB; Tang F; Chen H; Cid-Ruzafa J; Fenici P; Khunti K; Rathmann W; Shestakova MV; Surmont F; Watada H; Medina J; Shimomura I; Saraiva GL; Cooper A; Nicolucci A
    Front Endocrinol (Lausanne); 2022; 13():831676. PubMed ID: 35527995
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.